Open original FDA record ↗Recall record
- FDA identifier
- Z-0752-2024
- Company in FDA record
- Randox Laboratories Ltd.
- FDA classification date
- Jan 18, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
CK Total in Calibration Serum Level 3, CAL2351, is running with a positive bias on RX Series instruments compared to other methods experience a shift in Quality Control and patient sample recovery of up to 13%.
Source facts
- Action
- Randox issued Urgent Medical Device Correction Letter via email to the US and PR Distributors on 11/20/23. Distributors contacted the customer directly. The Letter states reason for recall, health risk and action to take: Action to be taken: " Discuss the contents of this notice with your Medical Director if you have used the RX Series targets for CK Total in the aforementioned lots. " Complete and return the response form, 12187-QA to technical.services@randox.com within five working days. " Please discard all copies of the IFUs and download the latest versions from www.randox.com. If you have any questions or concerns please contact Randox Technical Services.
- Initiated
- 2023-11-20
- Root cause
- Under Investigation by firm
- Distribution
- US Nationwide and Puerto Rico.
- Recall number
- Z-0752-2024
- Recall status
- Open, Classified
- CDRH record ID
- 204966
- FDA classified
- 2024-01-18
- Recall event number
- 93612